Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

CMS to begin replacing Medicare cards in 2018

New Medicare cards without Social Security numbers will be sent out starting in April 2018, according to CMS, meeting a deadline set by Congress to replace all cards by April 2019.

Swedish Health neurosurgeons double-booked surgeries without patients’ consent

Patients who thought their procedures at Seattle’s Swedish Neuroscience Institute (SNI) were being performed by top surgeons, but in reality, the surgeons were often running multiple operating rooms at once without telling the patients beforehand.

Dr. Sherine Gabriel, Dr. William A. Haseltine and Paul P. Tanico Join New York Academy of Medicine Board of Trustees

The New York Academy of Medicine welcomes to its Board of Trustees three leaders in medicine, science and business: Sherine E. Gabriel, MD, MSc, Professor & Dean of Rutgers Robert Wood Johnson Medical School and CEO of Rutgers Robert Wood Johnson Medical Group; William A. Haseltine, PhD, Chairman and President of ACCESS Health International, Inc. and founder of Human Genome Sciences, Inc.; and Paul P. Tanico, JD, Founder, Managing Principal and Chief Executive Officer of CastleRock Management.

Virtual reality in healthcare conference debuts in DC

As virtual reality (VR) continues to infiltrate the healthcare industry, connecting with the latest professionals and equipment from around the world becomes increasingly important. Addressing those factors, VR Voice has announced the first conference focusing on VR and its place in healthcare.

Thumbnail

Hospital CEO turnover remains high in 2016

Turnover among hospital CEOs was 18 percent in 2016, the same as in the prior two years, but remains among “the highest rates calculated in the last two decades,” according to the American College of Healthcare Executives (ACHE).

First look at Senate ACA replacment expected after recess

The U.S. Senate will be on break until June 3, but Senate Republican staff are expected to spend the recess drafting its own version of a bill to repeal and replace the Affordable Care Act (ACA).

Thumbnail

CBO report bolsters industry opposition to AHCA, worries some Republicans

Organizations representing hospitals and specialties reacted negatively to an estimate the Affordable Care Act (ACA) replacement passed by House Republicans would result in 23 million fewer people having insurance by 2026.

Metrics changing for U.S. News rankings on children’s hospitals

The methodology for ranking the country’s best children’s hospitals in U.S. News and World Report will contain “several noteworthy changes” affecting the top 10 overall list and the rankings for pediatric cardiology and heart surgery.

Displaying 4593 - 4600 of 6647

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup